OTU-01 The B-ADENOMA trial: a multicentre, randomised controlled trial of adenoma detection with endocuff vision

Walls, Martin; Brand, Andrew; Ngu, Wee Sing; Stokes, Clive; Sharp, Linda; Hoare, Zoë; Totton, Nikki; Bastable, Alexandra J.M.; Bhandari, Pradeep; Rees, Colin

doi:10.1136/gutjnl-2019-bsgabstracts.1

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prospective randomised controlled trial (RCT; ADENOMA TRIAL) showed an ADR of 40.9% versus 36.2% in the bowel cancer screening programme; 26 however, a prospective RCT in bowel scope patients (B-ADENOMA) showed no improvement compared with conventional endoscopy. 27 A recent systematic review and meta-analysis looking at 'behind fold visualising techniques' including cap-assisted ENDOCUFF VISION, EndoRings and FUSE showed no improvement in ADR compared with conventional colonoscopy although there was a significant improvement with G-Eye (Pentax, Japan) with an RR of 1.3. 28 Although colonoscopy remains the gold standard for investigation of the colon, there are those who are unable to tolerate complete optical colonoscopy.…”

Section: Improving Lesion Detectionmentioning

confidence: 99%

See 1 more Smart Citation

The evolution of lower gastrointestinal endoscopy: where are we now?

Sivananthan

Glover

Ayaru

et al. 2020

Clin Med Insights Gastroenterol

View full text Add to dashboard Cite

Lower gastrointestinal endoscopy has evolved over time, fulfilling a widening diagnostic and therapeutic remit. As our understanding of colorectal cancer and its prevention has improved, endoscopy has progressed with improved diagnostic technologies and advancing endoscopic therapies. Despite this, the fundamental design of the endoscope has remained similar since its inception. This review presents the important role lower gastrointestinal endoscopy serves in the prevention of colorectal cancer and the desirable characteristics of the endoscope that would enhance this. A brief history of the endoscope is presented. Current and future robotic endoscopic platforms, which may fulfil these desirable characteristics, are discussed. The incorporation of new technologies from allied scientific disciplines will help the endoscope fulfil its maximum potential in preventing the increasing global burden of colorectal cancer. There are a number of endoscopic platforms under development, which show significant promise.

show abstract

Section: Improving Lesion Detectionmentioning

confidence: 99%

Section: Improving Lesion Detectionmentioning

confidence: 99%